Regulatory · source year

1997 regulatory records

11 selected, source-linked regulatory records dated 1997. This is selective source coverage, not a complete timeline.

Dated records

11 selected records.

Peptide profiles

7 connected profiles.

Cited sources

11 distinct public records.

Cited chronology

Dated source records

All record types in 1997 →

December 1997

1 record

Eptifibatide

Federal Register notice 97-32874

The Federal Register published notice 97-32874, attributed to FDA and its parent HHS department, on 1997-12-17. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Eptifibatide.

Source: Federal Register via GovInfo ↗

→

November 1997

1 record

Desmopressin

Federal Register notice 97-30614

The Federal Register published notice 97-30614, attributed to FDA and its parent HHS department, on 1997-11-21. Its official title is “Determination That Desmopressin Acetate Nasal Solution 0.01% (for Refrigerated Storage) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.

Source: Federal Register via GovInfo ↗

→

October 1997

1 record

September 1997

1 record

August 1997

1 record

Oxytocin

Federal Register notice 97-20871

The Federal Register published notice 97-20871, attributed to FDA and its parent HHS department, on 1997-08-07. Its official title is “Sterling Drug, Inc., et al.; Withdrawal of Approval of 28 New Drug Applications, 9 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

July 1997

2 records

Oxytocin

Federal Register notice 97-19065

The Federal Register published notice 97-19065, attributed to FDA and its parent HHS department, on 1997-07-21. Its official title is “Babineaux's Veterinary Products, Inc., et al.; Withdrawal of Approval of NADA's,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

Oxytocin

Federal Register rule 97-19066

The Federal Register published rule 97-19066, attributed to FDA and its parent HHS department, on 1997-07-21. Its official title is “Animal Drugs, Feeds, and Related Products,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

June 1997

1 record

Oxytocin

Federal Register rule 97-16967

The Federal Register published rule 97-16967, attributed to FDA and its parent HHS department, on 1997-06-30. Its official title is “Animal Drugs, Feeds, and Related Products; Change of Sponsor,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

April 1997

2 records

Goserelin

Federal Register notice 97-10911

The Federal Register published notice 97-10911, attributed to FDA and its parent HHS department, on 1997-04-28. Its official title is “Environmental Assessments and Findings of No Significant Impact,” and PeptideScanner's exact reviewed identity mapping connects the document to Goserelin.

Source: Federal Register via GovInfo ↗

→

Mecasermin

Federal Register notice 97-10541

The Federal Register published notice 97-10541, attributed to FDA and its parent HHS department, on 1997-04-23. Its official title is “Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.

Source: Federal Register via GovInfo ↗

→

March 1997

1 record